Thadhani, R., Guilatco, R., Hymes, J., Maddux, F. W., & Ahuja, A. (2018). Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit(TM)) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis. Am J Nephrol.
Chicago Style citaatThadhani, Ravi, Ruffy Guilatco, Jeffrey Hymes, Franklin W. Maddux, en Ajay Ahuja. "Switching From Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit(TM)) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults On Hemodialysis." Am J Nephrol 2018.
MLA citatieThadhani, Ravi, et al. "Switching From Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit(TM)) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults On Hemodialysis." Am J Nephrol 2018.